Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.

Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)

Guangzhou Baiyunshan Pharmaceutical Holdings

Proxy Form For The Third Extraordinary General Meeting In 2025

Announcements and Notices - [Notice of EGM/SGM / Closure of Books or Change of Book Closure Period]

Notice Of The Third Extraordinary General Meeting In 2025

(1) Proposed Asset-Backed Securitization Of Accounts Receivable By Gp Corp.; (2) Proposed Settlement Of Projects Invested By Proceeds And Permanent Replenishment Of Working Capital From The Remaining Proceeds; And (3) Notice Of The Egm

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)

Proxy Form For The Third Extraordinary General Meeting In 2025

Notice Of The Third Extraordinary General Meeting In 2025

(1) Proposed Asset-Backed Securitization Of Accounts Receivable By Gp Corp.; (2) Proposed Settlement Of Projects Invested By Proceeds And Permanent Replenishment Of Working Capital From The Remaining Proceeds; And (3) Notice Of The Egm

Proposed Disposals Of Accounts Receivable

Monthly Returns

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)